These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22575355)

  • 1. Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project.
    Lovallo WR; King AC; Farag NH; Sorocco KH; Cohoon AJ; Vincent AS
    Psychoneuroendocrinology; 2012 Dec; 37(12):1922-8. PubMed ID: 22575355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute HPA axis response to naltrexone differs in female vs. male smokers.
    Roche DJ; Childs E; Epstein AM; King AC
    Psychoneuroendocrinology; 2010 May; 35(4):596-606. PubMed ID: 19837518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.
    King AC; Schluger J; Gunduz M; Borg L; Perret G; Ho A; Kreek MJ
    Neuropsychopharmacology; 2002 Jun; 26(6):778-88. PubMed ID: 12007748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke.
    al'Absi M; Wittmers LE; Hatsukami D; Westra R
    Psychosom Med; 2008 Oct; 70(8):928-35. PubMed ID: 18799426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME
    Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
    Kiefer F; Jahn H; Otte C; Naber D; Wiedemann K
    Biol Psychiatry; 2006 Jul; 60(1):74-6. PubMed ID: 16483549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early life adversity diminishes the cortisol response to opioid blockade in women: Studies from the Family Health Patterns project.
    Lovallo WR; Acheson A; Vincent AS; Sorocco KH; Cohoon AJ
    PLoS One; 2018; 13(10):e0205723. PubMed ID: 30312327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.
    Farren CK; O'Malley S; Grebski G; Maniar S; Porter M; Kreek MJ
    Alcohol Clin Exp Res; 1999 Mar; 23(3):502-8. PubMed ID: 10195825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of naltrexone administration on dehydroepiandrosterone sulfate levels in male and female participants.
    Ceballos NA; France CR; al'Absi M
    Biol Psychol; 2007 Mar; 74(3):414-6. PubMed ID: 16963172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB; Landman RE; Wardlaw SL; Conwell IM; Freda PU
    Pituitary; 2005; 8(2):115-22. PubMed ID: 16379031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical responses and family history of alcoholism.
    Wand GS; Mangold D; Ali M; Giggey P
    Alcohol Clin Exp Res; 1999 Jul; 23(7):1185-90. PubMed ID: 10443984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
    Williams KL; Ko MC; Rice KC; Woods JH
    Psychoneuroendocrinology; 2003 May; 28(4):513-28. PubMed ID: 12689609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
    Schluger JH; Ho A; Borg L; Porter M; Maniar S; Gunduz M; Perret G; King A; Kreek MJ
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1430-6. PubMed ID: 9802524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade.
    al'Absi M; Wittmers LE; Ellestad D; Nordehn G; Kim SW; Kirschbaum C; Grant JE
    Psychosom Med; 2004; 66(2):198-206. PubMed ID: 15039504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G.
    Lovallo WR; Enoch MA; Acheson A; Cohoon AJ; Sorocco KH; Hodgkinson CA; Vincent AS; Glahn DC; Goldman D
    Neuropsychopharmacology; 2015 Oct; 40(11):2546-54. PubMed ID: 25881118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol administration attenuates hypothalamic-pituitary-adrenal (HPA) activity in healthy men at low genetic risk for alcoholism, but not in high-risk subjects.
    Mick I; Spring K; Uhr M; Zimmermann US
    Addict Biol; 2013 Sep; 18(5):863-71. PubMed ID: 22260244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase.
    Roche DJ; King AC
    Psychoneuroendocrinology; 2015 Feb; 52():59-71. PubMed ID: 25459893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naltrexone on cortisol levels in heavy drinkers.
    Ray LA; Mackillop J; Leggio L; Morgan M; Hutchison KE
    Pharmacol Biochem Behav; 2009 Feb; 91(4):489-94. PubMed ID: 18824022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal.
    Besirli A; Eşel E; Özsoy S; Turan T
    Pharmacopsychiatry; 2014 Jul; 47(4-5):151-5. PubMed ID: 24936803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.